Holen Sie sich die Stockscreener-App
0.4963
11.69%
-0.0657
Vorhandelsmarkt:
.48
-0.0163
-3.28%
Schlusskurs vom Vortag:
$0.562
Offen:
$0.5933
24-Stunden-Volumen:
2.55M
Relative Volume:
0.57
Marktkapitalisierung:
$12.99M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-26.56M
KGV:
-0.7635
EPS:
-0.65
Netto-Cashflow:
$-22.29M
1W Leistung:
-23.65%
1M Leistung:
+19.59%
6M Leistung:
-44.16%
1J Leistung:
-72.97%
1-Tages-Spanne:
$0.478
$0.5933
1-Wochen-Bereich:
$0.4515
$0.6467
52-Wochen-Spanne:
$0.34
$1.90
BiomX Inc Stock (PHGE) Company Profile
Firmenname
BiomX Inc
Sektor
Branche
Telefon
972 7 23942377
Adresse
7 Pinhas Sapir Street, 2nd Floor, Ness Ziona
Vergleichen Sie PHGE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PHGE
BiomX Inc
|
0.4963 | 14.71M | 0 | -26.56M | -22.29M | -0.65 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.06B | 1.28B | -614.78M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
BiomX Inc Stock (PHGE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-04-15 | Eingeleitet | Ladenburg Thalmann | Buy |
BiomX Inc Aktie (PHGE) Neueste Nachrichten
BiomX outlines BX004 Phase IIb results expected in Q1 2026 as BX211 advances toward registrational study - MSN
BiomX Inc. Reports Q2 2025 Progress and Financials - TipRanks
BiomX Posts Q2 Loss With 14% Cost Drop - Nasdaq
BiomX's Q2 2025 Earnings Call: Unraveling Contradictions in BX211 and BX004 Development Strategies - AInvest
Trend analysis for BiomX Inc. this weekJuly 2025 Sector Moves & Short-Term High Return Ideas - Newser
Applying big data sentiment scoring on BiomX Inc.July 2025 Catalysts & Safe Investment Capital Preservation Plans - Newser
BiomX Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 - MarketScreener
Transcript : BiomX Inc., Q2 2025 Earnings Call, Aug 13, 2025 - MarketScreener
BiomX Inc. stock prediction for this week2025 Earnings Surprises & Low Risk Entry Point Guides - Newser
BiomX Inc (PHGE) Reports Q2 2025 EPS of -$0.33, Net Loss of $6 M - GuruFocus
BiomX Reports Second Quarter 2025 Financial Results and Provides Program Updates - TradingView
News impact scoring models applied to BiomX Inc.July 2025 News Drivers & Weekly Chart Analysis and Trade Guides - Newser
Technical Models Suggest BiomX Inc. May Rebound Soon [July 2025 Breakouts]Risk Managed Investment Entry Signals - 선데이타임즈
BiomX: Positioning Phage Therapy as a High-Probability, High-Impact Play in the Antibiotic Resistance Crisis - AInvest
What Fibonacci levels say about BiomX Inc. reboundProfit Target & Advanced Swing Trade Entry Alerts - Newser
How to escape a deep drawdown in BiomX Inc.Market Volume Summary & Reliable Momentum Entry Alerts - Newser
Analyzing drawdowns of BiomX Inc. with statistical tools2025 Market Overview & Low Risk Growth Stock Ideas - Newser
Can trapped investors hope for a rebound in BiomX Inc.Index Update & Fast Entry High Yield Stock Tips - Newser
BiomX Earnings Preview: What to Expect on August 13th - AInvest
BiomX Inc.’s Price Action Aligns with Quant SignalsBreakout Confirmation With Entry Tracker Enabled - 선데이타임즈
What to Expect From BiomX's Earnings - 富途牛牛
What institutional flow reveals about BiomX Inc.Multi-Bagger Detection with Trend Tools - Newser
Should you wait for a breakout in BiomX Inc.Free Weekly Growth Stock Entry Point Alerts - Newser
Should I buy BiomX Inc. stock before earningsPredictive Analytics for Equity Growth Potential - Newser
Can BiomX Inc. hit a new high this monthIntraday Price Action Forecast Planner - Newser
Why BiomX Inc. is moving todayTrend Analysis for Safer Market Entries - Newser
BiomX (PHGE) Projected to Post Earnings on Wednesday - Defense World
Earnings visualization tools for BiomX Inc.Technical Trade Plan with Entry Checklist - Newser
Is it time to cut losses on BiomX Inc.Algorithmic Prediction of Market Breakouts - Newser
Applying chart zones and confluence areas to BiomX Inc.Equity Portfolio Outlook and Performance Summary - Newser
Will BiomX Inc. Benefit From Broader Market BounceMarket Momentum Signal Generator Shows Trends - beatles.ru
Will BiomX Inc. price bounce be sustainableBull Market Summary and Recovery Outlook - Newser
Trendline Breach Raises Concern for BiomX Inc. InvestorsTrade Ready Stock Watch for Short Term Published - beatles.ru
Tick level data insight on BiomX Inc. volatilityAlgorithmic Prediction of Market Breakouts - Newser
Momentum divergence signals in BiomX Inc. chartBuy Strategy Review With Performance Summary - Newser
BiomX (PHGE.A) Plummets 19%: A Deep Dive Into the Sudden Drop - AInvest
BiomX Plunges 14.14% Ahead of Earnings Report - AInvest
Earnings Preview: BiomX to Report Financial Results Pre-market on August 13 - 富途牛牛
BiomX (PHGE.A) Suffers Sharp Intraday Drop – What’s Behind the Selloff? - AInvest
Biomx Inc. shares fall 5.85% intraday as Signal Advance Inc. engages with U.S. Congressmen on cybersecurity. - AInvest
BiomX Plunges 20.31% Amid Biotech Volatility - AInvest
BiomX Stock Plunges 19.69% Amid Investor Sentiment Shift - AInvest
Market Wrap-Up: Earnings, Acquisitions, and Tariffs Drive Market Movements - AInvest
BiomX (PHGE) Surges 53% on Morgan Stanley Stake and Earnings Hype: Is This a Short-Lived Rally or a Breakout Play? - AInvest
BiomX (PHGE.A) Surges 21.5%: A Technical and Order-Flow Deep Dive - AInvest
BiomX to Report Second Quarter 2025 Financial Results and Program Updates on August 13, 2025 - The Manila Times
BiomX Earnings: Novel Phage Therapy Pioneer Reveals Q2 2025 Results and Pipeline Progress - Stock Titan
Why Is BiomX Stock (PHGE) Up 40% Today? - TipRanks
BiomX Stock Soars 53.33% on Earnings Surge - AInvest
BiomX Stock Soars 35.47% on Earnings Surge - AInvest
Trending Stocks Today | BiomX Shoots up 41.47% Pre-Market - 富途牛牛
Finanzdaten der BiomX Inc-Aktie (PHGE)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):